## Common ground
All options refer to eltrombopag olamine tablets, a medicinal product used to treat thrombocytopenia.
## Options at a glance
**3003.90 – Not for retail sale**
- **Defining trait:** Sold in bulk or non-retail packaging, not pre-measured for individual use.
- **Typical examples:** Bulk tablets supplied to hospitals or pharmacies for repackaging.
- **Best fit when:** The product is intended for institutional use or further distribution, not direct patient consumption.
**3004.60 – For retail sale**
- **Defining trait:** Packaged in pre-measured doses (e.g., blister packs, bottles) ready for direct consumer purchase.
- **Typical examples:** Patient-ready packaging with daily dose labels and instructions.
- **Best fit when:** The product is sold directly to patients through pharmacies or online retailers.
## Key differences
| Criteria | 3003.90 – Not for retail sale | 3004.60 – For retail sale |
|------------------------|--------------------------------------|----------------------------------------|
| Packaging | Bulk, non-measured | Pre-measured, patient-ready |
| Distribution channel | Hospitals, wholesalers | Pharmacies, consumers |
| Labeling | No dosage instructions for patients | Includes dosing info and warnings |
## How to choose
- Is the product packaged in individual doses (e.g., blister packs)? → 3004.60
- Is it supplied in bulk without dose-specific packaging? → 3003.90
## Overlaps & pitfalls
A product may appear to fit both if it’s sold in measured doses but not labeled for retail use. However, the key distinction is **intended end-use**: if the packaging is designed for patient self-administration (with dosing info), it belongs under 3004.60. If it's for institutional or wholesale use without consumer-ready features, use 3003.90. The main function determines the classification—do not assume retail intent based on dose size alone